Business Context and Reporting Period
FutureCrest Acquisition Corp., a Cayman Islands-based emerging growth company, filed this Form 8-K on September 29, 2025, to report the consummation of its initial public offering (IPO). The company is incorporated in the Cayman Islands with principal executive offices in New York, NY.
Key Financial Metrics
- Gross Proceeds from IPO: $287,500,000 from the sale of 28,750,000 Units at $10.00 per Unit (including 3,750,000 Units from the full exercise of the underwriters' over-allotment option).
- Gross Proceeds from Private Placement: $7,000,000 from the sale of 3,500,000 Private Placement Warrants at $2.00 per warrant.
- Total Funds in Trust: $287,500,000 ($10.00 per Unit) deposited in a U.S.-based trust account maintained by Continental Stock Transfer & Trust Company.
- Deferred Underwriting Discount: $12,250,000 included in the net proceeds calculation.
- Warrant Exercise Price: $11.50 per share for both public and private placement warrants.
Material Changes
This filing represents the company's initial public offering and the transition from a private entity to a publicly traded company on the New York Stock Exchange (NYSE). The filing details the issuance of three classes of securities: Units (FCRS.U), Class A ordinary shares (FCRS), and redeemable warrants (FCRS WS). No prior comparable period financial data is provided in this specific filing as it marks the commencement of public trading.
Outlook, Risks, and Management Commentary
The filing confirms the successful closing of the IPO and the simultaneous private placement. The proceeds are held in a trust account, which is standard for Special Purpose Acquisition Companies (SPACs) to fund a future business combination. The filing does not provide specific forward-looking guidance, risk factors, or management commentary beyond the transaction details. An audited balance sheet as of September 29, 2025, is included as Exhibit 99.1.
Investor Verification Checklist
- Verify the terms of the trust agreement and the conditions under which funds may be withdrawn.
- Review the audited balance sheet (Exhibit 99.1) for the exact cash position and initial liabilities.
- Confirm the redemption rights associated with the Class A ordinary shares and the expiration terms of the warrants.
- Check the underwriting agreement for details on the deferred discount and any other underwriter fees.
- Monitor future filings for the identification of a target business combination.